Skip to Main Content

Author Details

Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
2007
35
21
PMIDPaper TitleJournal TitlePublished Year
37211455Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study.Lancet Digit Health2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
35074179The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.Pathology2022
31348742Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscleinvasive bladder cancer? The jury is still out but the answer is likely no.Can Urol Assoc J2020
32081560A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.Urol Oncol2020
33263367Trimodal therapy in muscle invasive bladder cancer management.Minerva Urol Nefrol2020
32712139Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.Urol Oncol2020
30642612Further Evidence of Differences in Prostate Cancer Biomarkers Between Caucasian and Asian Men.Eur Urol2019
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28410011Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.J Clin Oncol2017
26785120Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia.PLoS One2016
27376131Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.Bladder Cancer2016
24951361Positive surgical margins: race or surgeon?Eur Urol2015
25963383Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.Prostate2015
25955301Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts.Int J Oncol2015
24594406The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.J Urol2014
25199720Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancer.Eur Urol2014
25012523Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men.Eur Urol2014
24914839Prevalence of prostate cancer across the globe: what can autopsy studies teach us about this peculiar disease?Arch Esp Urol2014
22883484Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.Eur Urol2013
23847245Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.J Natl Cancer Inst2013
22812520Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors.Platelets2013
22810052Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.World J Urol2013
22321341Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.BJU Int2012
22551360Does patient age affect survival after radical cystectomy?BJU Int2012
21276177Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.BJU Int2011
21458152Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer.Eur Urol2011
21070579Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.BJU Int2011
19883638Nidogen-2: a new serum biomarker for ovarian cancer.Clin Biochem2010
21110756Optimal timing of radical cystectomy in T1 high-grade bladder cancer.Expert Rev Anticancer Ther2010
20882128Role of surgery in high-risk localized prostate cancer.Curr Oncol2010
19047685Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.Mol Cell Proteomics2009
19663500Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.J Proteome Res2009
17518992Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.Exp Dermatol2007
17459012Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.Br J Dermatol2007
  • 1 - 35 of 35

Recommended Authors

Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 2
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 12
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 9
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 18
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 5
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 6
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 3
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 13
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 3
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 2
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 3
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 4
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 6
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 10
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 6
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 5
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 17
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 4
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 9
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 3
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 9
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 16
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 15

Collaborators

Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 26
Neil E Fleshner
University of Toronto
Co-authored papers 16
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 12
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 10
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 8
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 6
Robert G Bristow
University of Toronto
Co-authored papers 5
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 5
Sally Hanna
Mount Sinai Hospital
Co-authored papers 4
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 4
Tristan Juvet
Lions Gate Hospital
Co-authored papers 3
Bharati Bapat
Mt Sinai Hospital
Co-authored papers 3
Katherine Lajkosz
Princess Margaret Hospital
Co-authored papers 3
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 3
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 2
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 1
David T Miyamoto
Massachusetts General Hospital
Co-authored papers 1
Karen Chadwick
University Health Network, University of Toronto
Co-authored papers 1
John R Srigley
University of Toronto
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Adree Khondker
University of Toronto
Co-authored papers 1
Andrzej Niemierko
Massachusetts General Hospital
Co-authored papers 1
Alistair E W Johnson
The Hospital for Sick Children
Co-authored papers 1
Benjamin J Blencowe
University of Toronto
Co-authored papers 1
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Release 1.2